Original document(20 pages)  中文版
    An adenovirus associated virus carrier configurator for treating Parkinson's disease by tetracycline to induce expression system and carry and regulate human GDNF and TH genes features that the adenovirus associated virus carrier provided on carrier has bidirectional promoter, two therapeutic genes and regulatory element betwene two terminals ITR, ITR. The method for introducing the said carrier in cells, screening and transplanting it in cerebral striate body or mixing with tetracycline transcriptional activator carrier for therapy is also disclosed.
Application Number
申请号		 02100103 Application Date
申请日		 2002.01.04
Title 名称 Recombination adenopathy adjoint virus carrier capable of controlling digene expression for treating parkinsonism
Publication Number
公开号		 1429905 Publication Date
公开日		 2003.07.16
Approval Pub. Date Granted Pub. Date
International Classification 分类号 A61K31/7088,A61P25/16,A61P25/28,C12N15/11,C12N15/33,C12N15/861,C12P19/34,C12P21/04
Applicant(s) Name
申请人		 Beijing Univ.
Address 地址 100083
Inventor(s) Name 发明人 Wang Xiaomin, Niu Dongbin
Attorney & Agent 代理人
More information 更  多  信  息


 Related patents information
Microstrip multi-way non-uniform power distributing and synthesing device
Microstrip multi-channel, multi-shift power divider/synthesizer
Application of tripterygium plant extract in preventing and curing diseases in nervous system
Three-ingredient sandalwood guttate pill and its prepn and use
Composition of bitter tea and rhubarb horsetails and preparation method thereof
Composition of fresh rehmannia root and rhubarb horsetails and preparation method thereof
Method of nickel sulfate solution system chemical nickel plating on magnesium alloy
Method for electroplating zinc on magnesium alloy
Two-step electro-zine-plating method on magnesium alloy as chemically nickel-plating intermediate transition layer
Extraction of nicotine from waste tabacco leaf and offal by lactescence membrane method
Google
Note:All patent data come from State Intellectual Property Office of the People's Republic of China. If there were discrepancies between here and the State Intellectual Property office, the later is more accurate. The patent data is only for public exchange and learning purposes. We are not responsible for the adverse consequences with unverified use of the data.